Flow Traders U.S.’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Flow Traders U.S.'s NVS Position: Q1 2026 in Review
Flow Traders U.S. sold out of Novartis (NVS) in Q1 2026, closing a stake of 9,556 shares — an estimated $1.32M sold.
Flow Traders U.S. first reported a position in NVS in Q3 2013 and held it in 14 quarters. The position peaked at $4.57M in Q3 2013. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Flow Traders U.S. reported no remaining Novartis position as of Q1 2026 after selling out during the quarter.
- Flow Traders U.S. sold 9,556 Novartis shares in Q1 2026, an estimated $1.32M.
- Flow Traders U.S. first reported a position in Novartis in Q3 2013 and held it in 14 quarters.
- Flow Traders U.S.'s Novartis position peaked at $4.57M in Q3 2013.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Flow Traders U.S.'s 13F filing for Q1 2026, filed 15 May 2026.